在气候变化和人类活动的综合影响下,青海省生态环境发生了明显变化。在此背景下,以GIMMS NDVI 3g.v1为数据源,采用Sen+Mann-Kendal方法研究青海省1982-2015年植被覆盖区域NDVI时空变化,将趋势分析和R/S(rescaled range analysis)分析叠...在气候变化和人类活动的综合影响下,青海省生态环境发生了明显变化。在此背景下,以GIMMS NDVI 3g.v1为数据源,采用Sen+Mann-Kendal方法研究青海省1982-2015年植被覆盖区域NDVI时空变化,将趋势分析和R/S(rescaled range analysis)分析叠加,研究植被生长季NDVI变化的持续性特征,并揭示植被对气候变化及人类活动的响应规律。结果表明:1)近34年青海省植被NDVI整体呈从西北到东南的增加趋势;且变异系数显示,波动性较大地区集中在柴达木盆地周边和青南牧区西北部等植被NDVI较低的区域,波动性较小地区集中在祁连山东部、东部农业区和青南牧区东南部等植被NDVI较高的区域。2)近34年青海省植被NDVI整体呈增加趋势,增长率为0.38%·10a^(-1);且NDVI变化具有明显的阶段性,存在1994年和2000年两个突变点。3)近34年青海省植被改善区域(75.4%)远大于退化区域(24.6%),其中显著改善面积占植被覆盖区域面积的40.9%,退化区随时间变化在空间上表现出明显的转移现象。4)Hurst指数表明,青海省植被变化反持续性较强,趋势分析与Hurst指数叠加得出,由退化转为改善的区域占植被覆盖区面积的13.7%,由改善转为退化的区域占植被覆盖区面积的44.3%,另41.5%的区域无法确定未来变化趋势。5)青海省植被生长季NDVI受气候变化和人类活动的双重影响,且不同植被类型对气候变化的响应存在较大差异。展开更多
随着4G和5G技术的发展,3G退网是移动通信升级换代的必然趋势。3G退网势必会对使用3G网络的终端用户造成影响,顺利推进3G退网工作离不开对3G终端及此类终端用户的管理。3G网络除了承载3G终端的语音数据,还承载着4G非长期演进语音承载(voi...随着4G和5G技术的发展,3G退网是移动通信升级换代的必然趋势。3G退网势必会对使用3G网络的终端用户造成影响,顺利推进3G退网工作离不开对3G终端及此类终端用户的管理。3G网络除了承载3G终端的语音数据,还承载着4G非长期演进语音承载(voice over long-term evolution,VoLTE)终端的语音数据。因此,分析国内外的3G退网经验,综合考虑3G终端和4G非VoLTE终端的发展差异,从终端的制式、地域分布、终端类型、品牌等多个维度进行分析,并根据分析结果总结出3G终端的管理要素,助力3G退网顺利进行。展开更多
Intestinal dysbiosis and disrupted bile acid(BA)homeostasis are associated with obesity,but the precise mechanisms remain insufficiently explored.Hepatic protein phosphatase 1 regulatory subunit 3G(PPP1R3G)plays a piv...Intestinal dysbiosis and disrupted bile acid(BA)homeostasis are associated with obesity,but the precise mechanisms remain insufficiently explored.Hepatic protein phosphatase 1 regulatory subunit 3G(PPP1R3G)plays a pivotal role in regulating glycolipid metabolism;nevertheless,its obesity-combatting potency remains unclear.In this study,a substantial reduction was observed in serum PPP1R3G levels in high-body mass index(BMI)and high-fat diet(HFD)-exposed mice,establishing a positive correlation between PPP1R3G and non-12a-hydroxylated(non-12-OH)BA content.Additionally,hepatocyte-specific overexpression of Ppp1r3g(PPP1R3G HOE)mitigated HFD-induced obesity as evidenced by reduced weight,fat mass,and an improved serum lipid profile;hepatic steatosis alleviation was confirmed by normalized liver enzymes and histology.PPP1R3G HOE considerably impacted systemic BA homeostasis,which notably increased the non-12-OH BAs ratio,particularly lithocholic acid(LCA).16S ribosomal DNA(16S rDNA)sequencing assay indicated that PPP1R3G HOE reversed HFD-induced gut dysbiosis by reducing the Firmicutes/Bacteroidetes ratio and Lactobacillus population,and elevating the relative abundance of Blautia,which exhibited a positive correlation with serum LCA levels.A fecal microbiome transplantation test confirmed that the anti-obesity effect of hepatic PPP1R3G was gut microbiotadependent.Mechanistically,PPP1R3G HOE markedly suppressed hepatic cholesterol 7a-hydroxylase(CYP7A1)and sterol-12a-hydroxylase(CYP8B1),and concurrently upregulated oxysterol 7-a hydroxylase and Takeda G protein-coupled BA receptor 5(TGR5)expression under HFD conditions.Furthermore,LCA administration significantly mitigated the HFD-induced obesity phenotype and elevated non-12-OH BA levels.These findings emphasize the significance of hepatic PPP1R3G in ameliorating diet-induced adiposity and hepatic steatosis through the gut microbiota-BA axis,which may serve as potential therapeutic targets for obesity-related disorders.展开更多
The highly active antiretroviral treatment (HAART) has allowed people living with HIV to live longer with a better quality of life. However, toxicity and the emergence of drug resistance arise from HAART use. Therefor...The highly active antiretroviral treatment (HAART) has allowed people living with HIV to live longer with a better quality of life. However, toxicity and the emergence of drug resistance arise from HAART use. Therefore, new antiretroviral therapy is needed since no cure or vaccine is available against HIV. Virus-host interaction has been proven to be important in the last decade. Host factors such as the C-C chemokine receptor type 5 (CCR5), a receptor used by HIV to penetrate host cells, have led to the discovery of the Maraviroc, which is an antiretroviral medication used in the United States. In contrast, other factors like C-X-C Motif Chemokine Receptor 4 (CXCR4) and the Apolipoprotein B mRNA editing enzyme catalytic polypeptide-like 3G (APOBEC3G), a potent host defense factor against HIV, is under investigation. APOBEC3G antiviral activity remains a possible therapeutic target against HIV. This systematic review aimed to synthesize the available evidence on the role of APOBEC3G polymorphisms and their expression on HIV infection disease progression in Africa. We used Web of Science, PubMed, Embase, and Google Scholar and searched for relevant publications in French or English reporting on APOBEC3G polymorphisms association with HIV infection in African populations from January 2009 to May 2023. The PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-analyzes) was used to process for reporting systematic review. Fifteen studies were included, of which seven were on APOBEC3G polymorphisms and eight were on APOBEC3G expression. Among the APOBEC3G polymorphisms, the most studied was H186R or rs8177832. The average of the minor allele frequency of H186R of APOBEC3G available for the studies included in this study was 0.29 with a 95% CI (0.172;0.401) and varied from 0.108 reported in Uganda to 0.47 recorded from Burkina Faso. The polymorphism H186R was not associated with HIV status in Southern Africa. However, the referent allele of H186R was protective against HIV infection in Western Central Africa, while in West Africa, it was the minor allele (G) of H186R which was protective against HIV. This review warrants a need to increase research on APOBEC3G, from its variants to its hypermutations on the continent with an essential variety of HIV-1 subtypes, to impact the research on A3G-based anti-HIV strategies.展开更多
Background: Studies have shown a strong correlation between the growth of E2 in serum and estrone-3-glucuronide (E1-3G) in urine during ovarian stimulation. Thus, we developed theoretical models for using urinary E1-3...Background: Studies have shown a strong correlation between the growth of E2 in serum and estrone-3-glucuronide (E1-3G) in urine during ovarian stimulation. Thus, we developed theoretical models for using urinary E1-3G in ovarian stimulation and focused on their experimental verification and analysis. Methods: A prospective, observational pilot study was conducted involving 54 patients who underwent 54 cycles of ovarian stimulation. The goal was to establish the growth rate of urinary E1-3G during the course of stimulation and to determine the daily upper and lower limits of growth rates at which stimulation is appropriate and safe. Controlled ovarian stimulation was performed using two different stimulation protocols—an antagonist protocol in 25 cases and a progestin-primed ovarian stimulation protocol (PPOS) in 29 cases, with fixed doses of gonadotropins. From the second day of stimulation, patients self-measured their daily urine E1-3G levels at home using a portable analyzer. In parallel, a standard ultrasound follow-up protocol accompanied by a determination of E2, LH, and P levels was applied to optimally control stimulation. Results: The average daily growth rates in both groups were about 50%. The daily increase in E1-3G for the antagonist protocol ranged from 14% to 79%, while they were 28% to 79% for the PPOS protocol. Conclusion: This is the first study to analyze the dynamics of E1-3G in two different protocols and to estimate the limits of its increase during the entire course of the stimulation. The results confirm our theoretical model for the viability of using urinary E1-3G for monitoring ovarian stimulation.展开更多
文摘在气候变化和人类活动的综合影响下,青海省生态环境发生了明显变化。在此背景下,以GIMMS NDVI 3g.v1为数据源,采用Sen+Mann-Kendal方法研究青海省1982-2015年植被覆盖区域NDVI时空变化,将趋势分析和R/S(rescaled range analysis)分析叠加,研究植被生长季NDVI变化的持续性特征,并揭示植被对气候变化及人类活动的响应规律。结果表明:1)近34年青海省植被NDVI整体呈从西北到东南的增加趋势;且变异系数显示,波动性较大地区集中在柴达木盆地周边和青南牧区西北部等植被NDVI较低的区域,波动性较小地区集中在祁连山东部、东部农业区和青南牧区东南部等植被NDVI较高的区域。2)近34年青海省植被NDVI整体呈增加趋势,增长率为0.38%·10a^(-1);且NDVI变化具有明显的阶段性,存在1994年和2000年两个突变点。3)近34年青海省植被改善区域(75.4%)远大于退化区域(24.6%),其中显著改善面积占植被覆盖区域面积的40.9%,退化区随时间变化在空间上表现出明显的转移现象。4)Hurst指数表明,青海省植被变化反持续性较强,趋势分析与Hurst指数叠加得出,由退化转为改善的区域占植被覆盖区面积的13.7%,由改善转为退化的区域占植被覆盖区面积的44.3%,另41.5%的区域无法确定未来变化趋势。5)青海省植被生长季NDVI受气候变化和人类活动的双重影响,且不同植被类型对气候变化的响应存在较大差异。
基金supported by the National Key R&D Program of China[grant number 2022YFF0801301]the National Natural Science Foundation of China[grant number 41575033]+1 种基金the Fengyun Satellite Application Pioneer Project[grant number FY-APP-2022.0111]the Natural Science Foundation of Jiangsu Province[grant number BK20231148]。
文摘随着4G和5G技术的发展,3G退网是移动通信升级换代的必然趋势。3G退网势必会对使用3G网络的终端用户造成影响,顺利推进3G退网工作离不开对3G终端及此类终端用户的管理。3G网络除了承载3G终端的语音数据,还承载着4G非长期演进语音承载(voice over long-term evolution,VoLTE)终端的语音数据。因此,分析国内外的3G退网经验,综合考虑3G终端和4G非VoLTE终端的发展差异,从终端的制式、地域分布、终端类型、品牌等多个维度进行分析,并根据分析结果总结出3G终端的管理要素,助力3G退网顺利进行。
基金supported by the Natural Science Foundation for Young Scientists of China(Grant No.:82201545)the Natural Science Foundation of Jiangsu Province,China(Grant No.:BK20221221)+4 种基金the Practice Innovation Program of Jiangsu Province,China(Grant No.:KYCX21_2641)the Medical Science Foundation of Jiangsu Province,China(Grant No.:H2019007)the Key Medical Talents Training Project of Xuzhou,China(Grant No.:XWRCHT20220060)the Xuzhou“Pengcheng Talent”Youth Medical Reserve Talent Project,China(Grant No.:XWRCHT20220014)the Science and Technology Projects of Xuzhou,China(Grant No.:KC21061).
文摘Intestinal dysbiosis and disrupted bile acid(BA)homeostasis are associated with obesity,but the precise mechanisms remain insufficiently explored.Hepatic protein phosphatase 1 regulatory subunit 3G(PPP1R3G)plays a pivotal role in regulating glycolipid metabolism;nevertheless,its obesity-combatting potency remains unclear.In this study,a substantial reduction was observed in serum PPP1R3G levels in high-body mass index(BMI)and high-fat diet(HFD)-exposed mice,establishing a positive correlation between PPP1R3G and non-12a-hydroxylated(non-12-OH)BA content.Additionally,hepatocyte-specific overexpression of Ppp1r3g(PPP1R3G HOE)mitigated HFD-induced obesity as evidenced by reduced weight,fat mass,and an improved serum lipid profile;hepatic steatosis alleviation was confirmed by normalized liver enzymes and histology.PPP1R3G HOE considerably impacted systemic BA homeostasis,which notably increased the non-12-OH BAs ratio,particularly lithocholic acid(LCA).16S ribosomal DNA(16S rDNA)sequencing assay indicated that PPP1R3G HOE reversed HFD-induced gut dysbiosis by reducing the Firmicutes/Bacteroidetes ratio and Lactobacillus population,and elevating the relative abundance of Blautia,which exhibited a positive correlation with serum LCA levels.A fecal microbiome transplantation test confirmed that the anti-obesity effect of hepatic PPP1R3G was gut microbiotadependent.Mechanistically,PPP1R3G HOE markedly suppressed hepatic cholesterol 7a-hydroxylase(CYP7A1)and sterol-12a-hydroxylase(CYP8B1),and concurrently upregulated oxysterol 7-a hydroxylase and Takeda G protein-coupled BA receptor 5(TGR5)expression under HFD conditions.Furthermore,LCA administration significantly mitigated the HFD-induced obesity phenotype and elevated non-12-OH BA levels.These findings emphasize the significance of hepatic PPP1R3G in ameliorating diet-induced adiposity and hepatic steatosis through the gut microbiota-BA axis,which may serve as potential therapeutic targets for obesity-related disorders.
文摘The highly active antiretroviral treatment (HAART) has allowed people living with HIV to live longer with a better quality of life. However, toxicity and the emergence of drug resistance arise from HAART use. Therefore, new antiretroviral therapy is needed since no cure or vaccine is available against HIV. Virus-host interaction has been proven to be important in the last decade. Host factors such as the C-C chemokine receptor type 5 (CCR5), a receptor used by HIV to penetrate host cells, have led to the discovery of the Maraviroc, which is an antiretroviral medication used in the United States. In contrast, other factors like C-X-C Motif Chemokine Receptor 4 (CXCR4) and the Apolipoprotein B mRNA editing enzyme catalytic polypeptide-like 3G (APOBEC3G), a potent host defense factor against HIV, is under investigation. APOBEC3G antiviral activity remains a possible therapeutic target against HIV. This systematic review aimed to synthesize the available evidence on the role of APOBEC3G polymorphisms and their expression on HIV infection disease progression in Africa. We used Web of Science, PubMed, Embase, and Google Scholar and searched for relevant publications in French or English reporting on APOBEC3G polymorphisms association with HIV infection in African populations from January 2009 to May 2023. The PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-analyzes) was used to process for reporting systematic review. Fifteen studies were included, of which seven were on APOBEC3G polymorphisms and eight were on APOBEC3G expression. Among the APOBEC3G polymorphisms, the most studied was H186R or rs8177832. The average of the minor allele frequency of H186R of APOBEC3G available for the studies included in this study was 0.29 with a 95% CI (0.172;0.401) and varied from 0.108 reported in Uganda to 0.47 recorded from Burkina Faso. The polymorphism H186R was not associated with HIV status in Southern Africa. However, the referent allele of H186R was protective against HIV infection in Western Central Africa, while in West Africa, it was the minor allele (G) of H186R which was protective against HIV. This review warrants a need to increase research on APOBEC3G, from its variants to its hypermutations on the continent with an essential variety of HIV-1 subtypes, to impact the research on A3G-based anti-HIV strategies.
文摘Background: Studies have shown a strong correlation between the growth of E2 in serum and estrone-3-glucuronide (E1-3G) in urine during ovarian stimulation. Thus, we developed theoretical models for using urinary E1-3G in ovarian stimulation and focused on their experimental verification and analysis. Methods: A prospective, observational pilot study was conducted involving 54 patients who underwent 54 cycles of ovarian stimulation. The goal was to establish the growth rate of urinary E1-3G during the course of stimulation and to determine the daily upper and lower limits of growth rates at which stimulation is appropriate and safe. Controlled ovarian stimulation was performed using two different stimulation protocols—an antagonist protocol in 25 cases and a progestin-primed ovarian stimulation protocol (PPOS) in 29 cases, with fixed doses of gonadotropins. From the second day of stimulation, patients self-measured their daily urine E1-3G levels at home using a portable analyzer. In parallel, a standard ultrasound follow-up protocol accompanied by a determination of E2, LH, and P levels was applied to optimally control stimulation. Results: The average daily growth rates in both groups were about 50%. The daily increase in E1-3G for the antagonist protocol ranged from 14% to 79%, while they were 28% to 79% for the PPOS protocol. Conclusion: This is the first study to analyze the dynamics of E1-3G in two different protocols and to estimate the limits of its increase during the entire course of the stimulation. The results confirm our theoretical model for the viability of using urinary E1-3G for monitoring ovarian stimulation.
